Location History:
- New Taipei, TW (2022)
- Taipei, TW (2024)
Company Filing History:
3 out of 96 
1 out of 181 
1 out of 22 Years Active: 2022-2024
Title: Wei-Ting Sun: Innovator in Antibody Research
Introduction
Wei-Ting Sun is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 3 patents to his name, his work focuses on addressing critical health challenges through advanced medical solutions.
Latest Patents
Wei-Ting Sun's latest patents include groundbreaking research on humanized anti-human neurotensin receptor 1 antibodies and their applications. This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases related to NTSR1 activity and signaling, as well as a method or kit for detecting NTSR1 in a sample. Another notable patent involves antibody-drug conjugates containing an anti-mesothelin antibody. This immunoconjugate includes an antibody that specifically binds to an epitope in mesothelin, along with a linker and two conjugated payloads. The patent also provides a pharmaceutical composition comprising the immunoconjugate and methods for treating cancer.
Career Highlights
Throughout his career, Wei-Ting Sun has worked with esteemed organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Wei-Ting Sun has collaborated with notable colleagues, including Shih-Hsien Chuang and Wun-Huei Lin. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of biotechnology.
Conclusion
Wei-Ting Sun is a distinguished inventor whose work in antibody research is paving the way for new therapeutic approaches. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.